Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My take on all this banter is:
You really can't trust anyone 100% pro or con on any matter in life. Everyone has there own agenda, especially when it comes to the Benjamin's. The company's and the investors want to make money and when money is involved lies and corruption are always close by. Best scenario do your own DD and interpret it with a grain of salt, nothing is totally good or bad. My stance on GRNH is, I'm still holding all my shares because I believe it's a viable company with the potential to produce large gains. After November elections we should start to sea it all unfold. MJ sector is on fire and it will continue until every State and the Fed's make it totally legal, Med and Rec. My money is on GRNH you decide for yourself. GLTA
Every knows the DEA sucks and is in the pocket of big Pharma
Sanders joins Democrats criticizing DEA for marijuana decision
By David Weigel
August 11 at 3:42 PM ?
Sen. Bernie Sanders (I-Vt.) speaks during the first day of the Democratic National Convention in Philadelphia on July 25. (Paul Sancya/AP)
Sen. Bernie Sanders of Vermont led a chorus of critics after the Drug Enforcement Administration declined to allow the use of marijuana for medical purposes — the latest example of fast-changing politics in the war on drugs.
"People can argue about the pluses and minuses of marijuana, but everyone knows it's not a killer drug like heroin," Sanders wrote in a tweet, after the DEA announced that marijuana would remain a Schedule I drug with "no currently accepted medical use in the United States."
He was echoed by Democrats from mostly blue states and districts, who criticized the DEA for not going further to remove marijuana from the legal blacklist.
"The DEA should be spending its limited resources on targeting high priority narcotics rather than erecting roadblocks to medical marijuana," Rep. Ted Lieu (D-Calif.) said in a statement.
"The Drug Enforcement Administration’s decision to keep marijuana as a Schedule I drug is frustrating, unscientific and, frankly, out of touch," said Rep. Jared Polis (D-Colo.) "It is ridiculous to classify marijuana alongside other Schedule I drugs like heroin. This is further evidence that it is past time that Congress legalize and regulate marijuana like alcohol, using Colorado as an example."
On Twitter, several Democrats made the point more succinctly.
Hey Northern glad your stricken In, bought shares in the teens also.
Large Bank Working With Company Aiming to Tap Florida MMJ Market
One of the biggest financial institutions in the Tampa Bay area has extended a $100,000 line of credit to a company that hopes to capitalize on Florida’s upcoming medical marijuana industry.
Regions Bank is providing the credit line to Efftec International Inc., a Las Vegas-based firm that owns a majority stake in Future Farms, the Jacksonville Business Journal reported. Future Farms is a retail indoor garden and hydroponics center in Miami.
Future Farms plans on getting into the medical cannabis industry if Florida voters approve MMJ at the ballot box in November.
Efftec also announced in February that it was serving as a consultant to a cannabis grower in southern California.
According to a press release, Efftec received an $80,000 line of credit from Regions at 7% per annum to fund Future Farms’ expansion, and another $20,000 on a credit card for “working capital needs.”
The Regions Financial Corp. – a $126 billion company headquartered in Alabama which is the parent of Regions Bank – did not comment to the Jacksonville Business Journal on why it decided to grant the line of credit to Efftec, or on whether it will be working with other cannabis companies.
The number of financial institutions working with the cannabis industry in recent years has jumped dramatically: As of March, 301 banks were granting services to marijuana businesses, according to information obtained by the Associated Press.
Daily News | Briefs | Florida Medical Cannabis Business & Marijuana Legal News | Legal & Regulatory News for Marijuana Businesses | Sales, Funding & Banking News
August 11, 2016
North Dakota to Vote on Legalizing Medical Cannabis
August 10, 2016
DEA Will Open Doors to More Cannabis Research
August 10, 2016
Arizona Rec Initiative Qualifies for Ballot
August 10, 2016
BioTrackTHC Gets Top Score in Puerto Rico
August 10, 2016
Record Raise: Tuatara Lands $93M for Investments in Marijuana Businesses
The States will prevail
Large Bank Working With Company Aiming to Tap Florida MMJ Market
One of the biggest financial institutions in the Tampa Bay area has extended a $100,000 line of credit to a company that hopes to capitalize on Florida’s upcoming medical marijuana industry.
Regions Bank is providing the credit line to Efftec International Inc., a Las Vegas-based firm that owns a majority stake in Future Farms, the Jacksonville Business Journal reported. Future Farms is a retail indoor garden and hydroponics center in Miami.
Future Farms plans on getting into the medical cannabis industry if Florida voters approve MMJ at the ballot box in November.
Efftec also announced in February that it was serving as a consultant to a cannabis grower in southern California.
According to a press release, Efftec received an $80,000 line of credit from Regions at 7% per annum to fund Future Farms’ expansion, and another $20,000 on a credit card for “working capital needs.”
The Regions Financial Corp. – a $126 billion company headquartered in Alabama which is the parent of Regions Bank – did not comment to the Jacksonville Business Journal on why it decided to grant the line of credit to Efftec, or on whether it will be working with other cannabis companies.
The number of financial institutions working with the cannabis industry in recent years has jumped dramatically: As of March, 301 banks were granting services to marijuana businesses, according to information obtained by the Associated Press.
Daily News | Briefs | Florida Medical Cannabis Business & Marijuana Legal News | Legal & Regulatory News for Marijuana Businesses | Sales, Funding & Banking News
August 10, 2016
DEA Will Open Doors to More Cannabis Research
August 10, 2016
Arizona Rec Initiative Qualifies for Ballot
Hey Madd hanging in there, people selling cheap now may be very sorry they did. Anybody else holding? Up 20% so far today, maybe we see another 20% tomorrow or higher. Not giving up my shares just yet. Screw the DEA, if we get news before November this will pop big. Pick up cheapies while you can. GLTA
I purchased more last week but for now I'm holding 3/4 Mill Sh hoping for the best. No sense getting out right now my loss won't be much more if it tanks so might as well stick it out.
Record Raise: Tuatara Lands $93M for Investments in Marijuana Businesses
marijuana money
By Omar Sacirbey
A New York-based private equity firm has raised $93 million to pump into cannabis companies, giving it the largest pool of capital ever gathered for marijuana-related investments.
Tuatara Capital, founded in 2014, announced today that it has closed out its two funds and will use the capital to make equity investments in high-growth cannabis companies in the research & testing, cultivation, processing, consumer and retail sub-sectors.
Tuatara said its original fund target was $80 million, meaning the firm surpassed its goal by about 16%.
The amount is significantly larger than the $75 million raised by cannabis-focused private equity firm Privateer Holdings early last year.
“We are humbled by the enthusiastic support of our limited partners, many of whom are close friends and long-time business associates,” Mark Zittman, chairman and founding partner of Tuatara, said in a statement.
Al Foreman, the firm’s chief investment officer, told Marijuana Business Daily that individuals accounted for the bulk of the investors in addition to some “quasi” institutions he declined to identify.
Tuatara aims to target approximately 10-15 marijuana businesses for investment, company executives said. The company plans to invest the $93 million over the next two to four years.
Maryland MMJ Program Proceeds After Initial OK for Growers, Processors
maryland marijuana
By Omar Sacirbey
Maryland’s long-delayed medical marijuana program is finally getting off the ground now that regulators have given preliminary approval to 15 growers and 15 processors.
The development sets a clear path for the emergence of the state’s MMJ industry, which is expected to become one of the largest on the East Coast.
But concerns over the application scoring process are already emerging, which could lead to lawsuits and potentially bog down the program.
The Maryland Medical Cannabis Commission moved the program forward last week by announcing it has selected preliminary winners of cultivation and processing licenses. Officials plan to reveal the names of the chosen companies on Aug. 15.
Vanessa Lyon, a spokeswoman for the commission, said winning applicants will be notified via email shortly before the public announcement.
“Our goal is late morning,” said Lyon, referring to the notifications.
Dispensary application winners will be announced in September, and the first storefronts are expected to open next year.
The state could award more than 100 dispensary licenses, dwarfing other markets on the East Coast. Sales could hit an estimated $20 million to $40 million in the first full 12 months after dispensaries open, according to the 2016 Marijuana Business Factbook, and eventually climb into the hundreds of millions.
Long Time Coming
Maryland officials initially aimed to have the state’s medical cannabis program operating by the second half of this year, but they were slowed by a flood of program applicants and other delays.
The state technically legalized medical marijuana years ago, but the law was largely seen as unworkable from a business perspective.
In 2014, Maryland lawmakers revamped the law by establishing a framework of rules similar to those found in other medical marijuana states. The new program dissolved the state’s previous MMJ plan.
The state received 146 grower applications, 124 processor applications and 811 dispensary license applications. The Towson University Regional Economic Studies Institute is evaluating the applications, giving each one a score that takes into consideration factors such as experience and security.
The scored applications for cultivators and processors, which have been redacted, were sent to the commissioners for final selection.
“The commission is now in the process of unlocking the coded applications,” Lyon said.
She noted the soon-to-be-announced winners must still undergo financial and background checks and fulfill other requirements before being allowed to proceed with the process.
Early Controversy?
But the evaluation process could already be clouded with controversy. One applicant, who asked not to be named, reported hearing that some companies have been told that their approval is “in the bag.”
Lyon denied there were any leaks. “No notifications have been made,” she said.
Commissioners picked 13 of 15 of the highest-ranked grower applicants, while two of the top contenders were bumped from the list in favor of two other applicants that officials believed would add more geographic diversity to the pool of cannabis growers, the Baltimore Sun reported.
Some applicants found that suspicious and wondered why the two companies that were bumped weren’t asked if they wanted to relocate before giving the licenses to lower scoring companies.
Ethics concerns were also raised in July when the Washington Post reported that one Maryland state lawmaker who pushed for medical marijuana legalization, State House member Dr. Dan Morhaim, is also the clinical director of Doctor’s Orders, which applied for grow, processing and dispensary licenses.
For applicants, the news of a looming announcement is welcome after such a long wait.
But they are trying not to get overly excited, even though Maryland could become one of the hottest East Coasts markets.
“For us, it’s just a matter of waiting,” said Steve White, CEO of Arizona-based Harvest Inc., which applied for cultivation, processing and dispensary licenses under the name Harvest of Maryland. “I’m trying to not think about it. We have enough stuff going on.”
Jessica White – whose team applied for processing and dispensary licenses under the names FGM Processing and Cannavations MD, respectively – said she sees two groups of applicants.
‘There are those that are going out and aggressively pursuing capital, and there are those that are in a holding pattern,” she said. “We are somewhere in between.”
White said her group has garnered serious interest from investors but hasn’t been able to get a commitment from them without a license.
“They want to invest but they’re not committing until we get a license,” White said. “Who can blame them?”
Securing Real Estate
If White’s Cannavations team wins licenses, they will also have to worry about securing real estate for any licenses they win. Her team had found properties for the processing facility and for three of four dispensary locations, as well as landlords willing to hold the real estate for them – but only until April 1.
Despite the setbacks, White has already found a new space for the processing facility, and had a list of backup spaces for the dispensaries. So she and her team are prepared to move quickly should they get a license.
“You can’t have a completely firm plan in place, but you can lay down the foundations and concepts. You have to know how you want your space to be, what you want from you employees, and how you’re going to train them,” White said. “If we get a license, we’re positioned to go full steam ahead.”
White of Harvest said his team is also ready to spring into action if it wins a license, and start their grow site build-out in the town of Hancock, in western Maryland, where they have have secured a location.
“If you’re somebody who is still scrambling at this point to prepare for the next steps, you probably won’t be prepared,” White said.
August 10, 2016
Record Raise: Tuatara Lands $93M for Investments in Marijuana Businesses
August 10, 2016
Canadian Expert: Allow Small-Scale Businesses Into Rec Industry
August 10, 2016
Canadian Cannabis Company’s Move to Large Stock Exchange Could Create Positive Ripple Effect
Hold on longs, this is day trader and weak hands action. GRNH will give us the returns we desire soon enough.
Hey Darth, I was mores concerned about Scotts getting into the Hydroponics end of the business rather then soil based. They seem to be buying Hydro based companies. GLTA
This sector is going to POP soon, I wish we had more exposer to the MJ sector.
Scotts Miracle-Gro’s Cannabis Play Boosts Stock Price
Marijuana appears to be lifting Scotts Miracle-Gro’s stocks to new highs.
On Thursday, a day after the Ohio-based lawn care giant announced that it had shelled out $40 million to buy Botanicare, an Arizona-based provider of marijuana nutrient and hydroponics products, JP Morgan stock analyst Jeffrey Zekauskas upgraded his outlook for the company’s stock by raising its target price by more than 20%, to $85 from $70, according to Barron’s. He also upgraded the stock to “overweight” from “neutral.”
“The hydroponics market taps into marijuana demand and the company now has a growth option that we think an investor is able to capture for about the price of the traditional business,” Zekauskas said, according to Barron’s.
Soon after Scotts’ stock was upgraded, it hit its all-time highest price, $80.14, Barron’s reported. On Friday, the stock closed at $79.56 on the New York Stock Exchange.
Zekauskas estimates that Scotts has about 50% of the nation’s lawn care product market share, even though sales have been subpar in recent years. Scott’s foray into hydroponics, however, will help the company’s long-term prospects, he predicted.
Earlier this year, Scotts bought Gavita, a European company that specializes in grow lighting and hardware, and has also invested in other cannabis-related companies.
Daily News | Briefs | Cultivation
This news sounds good but will it cut into GRNH business? opinions please
Scotts Miracle-Gro’s Cannabis Play Boosts Stock Price
Marijuana appears to be lifting Scotts Miracle-Gro’s stocks to new highs.
On Thursday, a day after the Ohio-based lawn care giant announced that it had shelled out $40 million to buy Botanicare, an Arizona-based provider of marijuana nutrient and hydroponics products, JP Morgan stock analyst Jeffrey Zekauskas upgraded his outlook for the company’s stock by raising its target price by more than 20%, to $85 from $70, according to Barron’s. He also upgraded the stock to “overweight” from “neutral.”
“The hydroponics market taps into marijuana demand and the company now has a growth option that we think an investor is able to capture for about the price of the traditional business,” Zekauskas said, according to Barron’s.
Soon after Scotts’ stock was upgraded, it hit its all-time highest price, $80.14, Barron’s reported. On Friday, the stock closed at $79.56 on the New York Stock Exchange.
Zekauskas estimates that Scotts has about 50% of the nation’s lawn care product market share, even though sales have been subpar in recent years. Scott’s foray into hydroponics, however, will help the company’s long-term prospects, he predicted.
Earlier this year, Scotts bought Gavita, a European company that specializes in grow lighting and hardware, and has also invested in other cannabis-related companies.
Daily News | Briefs | Cultivation
?
YesterdaysNews I had a similar reaction, just wanted to know if anyone knew about.
PS More news
Could Ohio Solve the Cannabis Industry’s Cash-Only Problem?
By Omar Sacirbey
Could Ohio wean the marijuana industry from its need to do business in cash?
Ohio’s new medical marijuana law proposes a “closed-loop” payment processing system. It would be similar to pre-paid debit or gift cards. Regulators must still decide whether to use the system.
The proposal comes at a time when legal marijuana companies have had to rely on cash-only transactions. That’s because most banks, credit unions and credit card companies are reluctant to do business with them, given the uncertain federal regulatory environment.
That conundrum has forced marijuana businesses to use cash to pay employees, buy lighting and other equipment, or pay taxes. Moreover, MJ business owners don’t have a safe place to keep all that cash, endangering employees and customers.
But could Ohio’s proposed closed-loop system solve such issues? Opinions are divided and several industry officials are skeptical – especially given that a small but growing number of financial institutions are serving MJ customers.
Still, some industry observers reckon the system could work. At the least, it could be a useful stopgap measure in new MMJ markets, such as Ohio or Pennsylvania, where banks are unaccustomed to cannabis businesses.
“It’s not completely out there. At the same time, you also have private businesses in states like Washington and Arizona who are offering different types of payment systems and stored-payment methods,” Robert McVay, an attorney with the law firm Harris Moure in Seattle, said.
How Ohio’s Closed-Loop System Would Work
Under Ohio’s proposed system, MMJ patients and registered caregivers would put money in special accounts, using checks, credit cards, or cash at a state-licensed liquor store or a state agency. The money in the accounts could be used for dispensary purchases.
Dispensaries, cultivators, and other marijuana businesses also would have accounts they could tap to buy products and pay bills. If a marijuana business needed to make a payment outside of the closed-loop system, the state would cut a check for the payee.
The Financial Crimes Enforcement Network would have access to every transaction – should the U.S. Treasury agency decide to investigate.
The Ohio Department of Commerce – which is in charge of establishing the MMJ program’s payment system – hasn’t yet made a decision about the closed-loop plan.
“We are just beginning the process to set up Ohio’s Medical Marijuana Control Program, and no decisions around a closed-loop payment system have been made at this time,” Kerry Francis, a spokeswoman for the Ohio Department of Commerce, said. “Also, there haven’t been any decisions around banking regulations.”
Could Ohio Solve the Cannabis Industry’s Cash-Only Problem?
By Omar Sacirbey
Could Ohio wean the marijuana industry from its need to do business in cash?
Ohio’s new medical marijuana law proposes a “closed-loop” payment processing system. It would be similar to pre-paid debit or gift cards. Regulators must still decide whether to use the system.
The proposal comes at a time when legal marijuana companies have had to rely on cash-only transactions. That’s because most banks, credit unions and credit card companies are reluctant to do business with them, given the uncertain federal regulatory environment.
That conundrum has forced marijuana businesses to use cash to pay employees, buy lighting and other equipment, or pay taxes. Moreover, MJ business owners don’t have a safe place to keep all that cash, endangering employees and customers.
But could Ohio’s proposed closed-loop system solve such issues? Opinions are divided and several industry officials are skeptical – especially given that a small but growing number of financial institutions are serving MJ customers.
Still, some industry observers reckon the system could work. At the least, it could be a useful stopgap measure in new MMJ markets, such as Ohio or Pennsylvania, where banks are unaccustomed to cannabis businesses.
“It’s not completely out there. At the same time, you also have private businesses in states like Washington and Arizona who are offering different types of payment systems and stored-payment methods,” Robert McVay, an attorney with the law firm Harris Moure in Seattle, said.
How Ohio’s Closed-Loop System Would Work
Under Ohio’s proposed system, MMJ patients and registered caregivers would put money in special accounts, using checks, credit cards, or cash at a state-licensed liquor store or a state agency. The money in the accounts could be used for dispensary purchases.
Dispensaries, cultivators, and other marijuana businesses also would have accounts they could tap to buy products and pay bills. If a marijuana business needed to make a payment outside of the closed-loop system, the state would cut a check for the payee.
The Financial Crimes Enforcement Network would have access to every transaction – should the U.S. Treasury agency decide to investigate.
The Ohio Department of Commerce – which is in charge of establishing the MMJ program’s payment system – hasn’t yet made a decision about the closed-loop plan.
“We are just beginning the process to set up Ohio’s Medical Marijuana Control Program, and no decisions around a closed-loop payment system have been made at this time,” Kerry Francis, a spokeswoman for the Ohio Department of Commerce, said. “Also, there haven’t been any decisions around banking regulations.”
Critics Weigh In
Critics of a state-run closed-loop system – like the Ohio plan – argue it wouldn’t shield banks from federal interference.
“It is possible that a mandatory closed-loop system could be established and banks would still prefer not to service the marijuana industry to cash checks from the state system,” said Tom Haren, an attorney with Ohio-based Seeley, Savidge, Ebert & Gourash.
Anyone know anything about this so called complaint against WOFA posted by FreezeThese. I've heard nothing about it or noticed any other post by this guy.
More good news from Minnesota:
Minnesota’s pair of MMJ producers got a big boost this past week when intractable pain patients were allowed to start buying at dispensaries.
That assessment is based on a reading from one of the companies.
“Essentially all of our dispensaries have been packed every day,” said Kyle Kingsley, CEO of Minnesota Medical Solutions, which operates four storefronts in Minneapolis, Rochester, Bloomington and Moorhead.
Kingsley estimated that sales at least doubled this week, if not tripled, for his company. His staff was so busy that he himself was on hand at one of the company locations to assist with patient consultations.
No one from LeafLine Labs, Minnesota’s other MMJ producer, could be reached for comment.
The main reason it’s such a big deal, particularly for Minnesota, is that it’s one of several MMJ markets that saw a disturbingly slow start, with less than 100 patients registered for the statewide program prior to its June 2015 launch.
But that number has slowly grown over the past year. Since intractable pain patients have been allowed to register as of July 1, more than 500 have already signed up, a staffer for the state program said. Specific pain patient numbers have not been made public.
“I was comfortable last year, and this certainly helps. This definitely puts some wind in our sails,” Kingsley said.
As of July 28, the state had registered 2,040 MMJ patients total.
Sector is heating up, come on WOFA change that name!
On a Roll: Illinois MMJ Patients Spend Record $2.9M in July
Despite a slow start, Illinois’ medical cannabis industry is gathering momentum as evidenced by the steady growth in sales throughout this year.
In July, the state’s industry hit a new high, with $2.9 million in sales, according to the Chicago Tribune.
That’s up from $2.57 million in June, for a grand total of $16.3 million since the program launched in November. Sales have been growing steadily since the first dispensary opened.
The patient count has been growing steadily as well, which accounts for the parallel sales growth: The state now has nearly 9,000 patients, up from about 4,800 in February.
Gov. Bruce Rauner, despite his administration’s repeated reluctance to support medical cannabis in general, has also finally relented and agreed to expand both the length of the pilot program (it won’t sunset now until 2020) and its qualifying condition list (it now includes post-traumatic stress disorder and terminal illnesses), giving the industry a much-needed boost.
Daily News | Briefs | Dispensary/Retail Store Business News | Illinois Medical Cannabis Business & Marijuana Legal News | Sales, Funding & Banking News
On a Roll: Illinois MMJ Patients Spend Record $2.9M in July
Despite a slow start, Illinois’ medical cannabis industry is gathering momentum as evidenced by the steady growth in sales throughout this year.
In July, the state’s industry hit a new high, with $2.9 million in sales, according to the Chicago Tribune.
That’s up from $2.57 million in June, for a grand total of $16.3 million since the program launched in November. Sales have been growing steadily since the first dispensary opened.
The patient count has been growing steadily as well, which accounts for the parallel sales growth: The state now has nearly 9,000 patients, up from about 4,800 in February.
Gov. Bruce Rauner, despite his administration’s repeated reluctance to support medical cannabis in general, has also finally relented and agreed to expand both the length of the pilot program (it won’t sunset now until 2020) and its qualifying condition list (it now includes post-traumatic stress disorder and terminal illnesses), giving the industry a much-needed boost.
Daily News | Briefs | Dispensary/Retail Store Business News | Illinois Medical Cannabis Business & Marijuana Legal News | Sales, Funding & Banking News
juana Business Factbook 20 Cannabis Cness day
Happy to see the large volume today and PPS move to 0.0005%. Defiantly something happing. GLTA
Why all the selling recently? Tired of seeing RED. I guess a lot of uncertainty. I'm holding and buying on the dips but would like to see a run soon.
More good news
On the Campaign Trail: Q&A With Congressman Earl Blumenauer
Earl Blumenauer Cropped
By John Schroyer
Earl Blumenauer is an Oregon congressman. Yet he’s traveled to places such as Maine to help pass marijuana legalization initiatives in several states this fall.
Blumenauer, a longtime marijuana advocate, recently took time to discuss national cannabis politics with Marijuana Business Daily.
Voters in nearly a dozen states may be voting in November on whether to legalize recreational or medical marijuana. The results could have enormous implications for the marijuana industry at both the state and national levels.
Blumenauer – a Democrat from a state where recreational and medical marijuana are legal – is going out of his way to help sway the upcoming elections. Last month, for example, he appeared in Las Vegas on behalf of the Campaign to Regulate Marijuana Like Alcohol, the group spearheading a Nevada ballot measure to legalize recreational cannabis.
Looking ahead to the fall, Blumenauer is for the most part bullish on the prospects for legalization.
Why the campaign stop in Nevada?
The Nevada campaign is an interesting one. It’s a very pivotal state. And it’s going to get a lot of attention this year, because half of the state’s congressional delegation is involved in competitive races. There’s also a competitive U.S. Senate race, and it’s a swing state presidentially. Also, some 50 million people come to Nevada every year – about 4 million a month go through Las Vegas. So if (recreational cannabis) wins in Nevada, it’s going to have a very profound impact. People from all over the country would be exposed to legal adult-use marijuana.
What else are you doing on behalf of legalization?
I’m planning on helping each of the state campaigns. I’ve already been meeting with people in California and in Maine. I’m going to be in Massachusetts. The Florida campaign is medical, but it’s huge. If it’s successful, it’ll be the second largest marijuana market in the country (after California). I’m also planning on doing some work in Arizona.
Up to 11 states across the country could be voting on legalization ballot measures, for either rec or medical. Care to offer any predictions?
I’m quite optimistic. I don’t want to give away any campaign secrets. But based on the work that I’ve done and the research I’ve reviewed, these campaigns – at this point – are ahead in every single state.
But that’s no guarantee that’s where we’re going to end up. Donald Trump could be the next president. But in California I think it’s going to pass overwhelmingly. I think we get MMJ in Florida. It got 58% in a non-presidential election (in 2014). And this year, based on the surveys that I’ve heard of and seen, it’s in the 70’s. I think it’s very strong in Maine. I suspect the medical marijuana initiative in Missouri is a pretty good bet. If there’s only one ballot measure in Arkansas, I think that passes.
All the other state campaigns are in the safety zone. They can pass if the people who care about it are willing to step up, if they’re willing to donate, if they’re willing to campaign, and if they’re willing to pin down elected officials. Massachusetts is going to be harder than people think. Unfortunately, there’s a Republican governor and some Democratic politicians who are against it. But there’s public support, and it’s doable. Nevada is a horse race. But it could pass there and in Arizona.
What kind of ramifications will there be in Washington DC if there are a number of cannabis victories across the country in November?
It really helps us. The ballot measures have forced a number of people to look at it. Maybe they were people who didn’t philosophically support it. But for us to be able to show them – ‘Marijuana is more popular in your district than you are,’ – that makes a difference. And we’ve worked very hard to make sure this not be a partisan issue.
I think we’re going to have an administration that’s going to continue to be supportive and does not get in the way. I think you’re most likely going to have Democratic control of the Senate. I think the stage is set to get across the finish line in the next Congress. I think we fix banking. I think we fix the unfair taxation. I think we fix the research prohibition.
You sound very optimistic.
I think in five years this game’s over. Medical marijuana will be available to people in every state, and most states will be treating marijuana like they treat alcohol. The train has left the station, if we all do our job this year.
This interview has been edited for length and clarity.
John Schroyer can be reached at johns@mjbizdaily.com
Daily News | Featured | Legal & Regulatory News for Marijuana Businesses | Recreational Marijuana News
?
I'm in for a long time gonna give it till end of August or maybe beginning of September then I'll make my decision. For now here is an interesting and heart felt article.
Would You Break The Law To Save Your Child’s Life?
?
Mo Barnhart loves her daughter. “I had Dahlia five years ago, so she’s five years old right now and was diagnosed with brain cancer when she was two. So I went from having this dancing, affectionate, happy, playing two year old baby girl to having this dying patient in a hospital bed over night, literally.”
As a single mom, her life changed radically once Dahlia started on Chemotherapy.
We lived solely to save Dahlia’s life.
“I had no idea that from the time of diagnosis on, that I would have literally no options.
The very first surgery that she underwent, they literally told me that if I didn’t agree to that surgery, they would do it without my permission, that if I did not agree to the conventional treatment options they were going to give me, which consist of surgery,
chemotherapy, and radiation, the state would take custody of her and she would undergo those treatments without me.
“These medical professionals are not evil, their hands are tied. We have some really bad laws.” Marijuana is Federally illegal and not considered to have any medical benefits which is why it is Schedule 1. This is why so little research is done in America.
According to the National Cancer Institute, Chemical components of Cannabis, called cannabinoids, activate specific receptors throughout the body to produce pharmacologic effects, particularly in the central nervous system and the immune system. Cannabis has been used for medicinal purposes for thousands of years.
Dahlia was prescribed some really harsh and dangerous drugs. Most of the medications come with side effects like psychosis, homicide, suicide, death, and that’s all we have to offer these children. Cannabis does not have any side effects.
“At some point the shock started to wear off. And a few months into treatment I realized
that my daughter was going to die unless I did something about it.
I looked up over the course of just a few months, thousands of supplements and alternative treatments. What I found time and time again was that cannabis was very efficient just for treating the symptoms and side effects of both the disease and its treatment.”
Mo let her medical professionals know that she was having cannabis shipped into an illegal state, in Tennessee, where St. Jude is. They we were all onboard.
I started her on cannabis oil about six months into treatment.
The very first night that she took oil, she slept through the night for the first time in her entire life. She gained three pounds the first week she was on oil. “All of the science, for or against in the world doesn’t even matter. You’re witnessing it with your own eyes.”
Mo was against drugs and against cannabis before Dahlia got sick.
“I’m just so ashamed to admit, but had this been on a ballot in front of me, I don’t think I would have voted for it. I also never had somebody sit down in front of me and explain to me that this was medicine.”
Mo is the co-founder of Florida’s, CannaMoms, it is an organization that helps to raise awareness of and education about CBD and Cannabis.
“The fact that we have not a single cure for a single disease for illness that these children suffer from, that’s all gonna be changed.”
Mo points to her daughter, Dahlia’s head and asks, “Was there something in here once?”
Dahlia looks at her mom and points to her head. “Yep, there was cancer in there.”
Mo asks, “And then what happened?”
Dahlia smiles, “We killed the cancer. My mom never gives up on her kids. Mommy, thank you, mom!” They hug.
Yes I keep getting the same busy signal, Let's hope they just don't want to divulge upcoming news just yet. GLTA
I called yesterday got a busy signal, will try again later.
It's all about the Benjamin's baby sooner or later all the states will have some sort of MMJ legalization, the revenue is just to astronomical to pass up. California and Nevada will pass medical and recreational use in November and the others will follow in the months ahead. Watch this ticker move as soon as California legalizes MMJ after the November vote.
Weather the DEA moves to reschedule or not, will not matter that much. The Feds will leave it up to each individual state to mandate there own laws concerning MMJ research and legalization. Also the over all economy for the country will be better for it. Those smart enough to invest now will be generously rewarded. GLTA
Found this and a telephone number (1-800-727-1024) I will call later, everyone should give a call.
California Will Vote to Legitimize Recreational Marijuana in 2016; Wisdom Homes Corporate Update
?
In California's race to legitimize recreational marijuana, at least 10 legalization initiatives are vying to appear on the state's November 2016 ballot. California is arguably the cultural and economic nucleus of the country's cannabis industry. Its numerous marijuana farms are estimated to produce 60 to 70 percent of all marijuana consumed in the country. What's more, legalization there would launch a cannabis market in what is the world's eighth largest economy according to IBTimes.com.
Separately but related, Gov. Jerry Brown has imposed statewide rules on the growth, transport and sale of cannabis. Signing three bills in October 2015, the governor created a regulatory system for medical cannabis that could be adapted for widespread use if voters make it legal by passing a 2016 ballot initiative.
WOFA believes the potential legalization and the statewide rules increase the overall value of the non-exclusive licensing rights that the Company has to CannaStrips. In the past five months the Company refocused all of its efforts back into the medicinal cannabis industry. After significant due diligence it identified a specific market segment, oral strips (similar to breath strips), providing an exacting and controlled dosage of cannabis, without the health risks associated with smoking or potential chemical inhalation associated with some smokeless inhalers. It has executed a licensing agreement with Canna Delivery Systems, Inc., a wholly owned subsidiary of Lifestyle Delivery Systems, Inc. in which the Company has the non-exclusive license to market CannaStrips throughout northern California. And it has secured manufacturing and distribution relationships, as well as received orders.
Recommended for you: Homes For Sale - See Homes For Sale By Zip.
RealtyNow.com/Homes_For_Sale | Sponsored
Corporate Update
As a result of discontinuing operations in the housing market and re-focusing on the cannabis industry, as well as the large number of equity transactions in 2015 during the transition, the Company has experienced a significant increase in the number of accounting transactions which has caused a delay in filing our 10-K within the extended timeline. The Company is aggressively working to complete the filing and will provide an update within ten days if the filing has not been completed. Subsequent to the filing the Company plans to perform a variety of corporate changes including file for its name change and the re-location of corporate offices.
Wisdom Homes of America, Inc., located in Tyler, Texas, has discontinued its manufactured housing retail centers. The Company concentrates on licensing products and technology that benefit the cannabis patient and consumer. The Company's common stock trades on the OTC Pink market under the ticker symbol "WOFA".
Safe Harbor Notice
Certain statements contained herein are "forward-looking statements". Wisdom Homes of America, Inc. cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. Wisdom Homes of America, Inc. undertakes no obligation to revise these statements following the date of this news release.
Wisdom Homes of America, Inc.
(800) 727-1024
call.
I owned shares of WOFA prior to the change over to the MJ sector and I took a leap of fait (which I usually never do) and bought more shares over the last five months.
At this point it's Ludacris that we have no word from them in over three months. All the longs on this board need to seriously do what ever DD is necessary to find out a contact number and call or E-mail them for information. GLTA
Tic tock is right, it's almost August and no news for months. We need this company to move on the name change and fiscal information. After August the MJ sector will most likely start it's run up and we need to be on the map. A PR would be nice at this time, although I am holding 3/4 Million Shares, I am tired of being kept in the dark. A little respect for the share holders would be appreciated WOFA, give us some news.
cannabis investments
By John Schroyer
Out-of-state investors are pumping millions of dollars into Oregon’s marijuana industry now that a restrictive residency requirement has been abolished, giving local cannabis businesses a sorely needed pipeline of money to tap as they grow.
In March, Oregon’s governor signed a law eliminating a rule that required every legal marijuana business to be at least 51% owned by an Oregon resident who lived in the state for at least two years.
As a result, cannabis companies are now free to raise money from out-of-state investors in exchange for equity, making the market much more attractive to deep-pocketed individuals and firms looking to fund marijuana businesses.
“For every five people who came into my office, three or four of them were looking for capital, and they couldn’t find it here in Oregon,” said Portland attorney Amy Margolis, who is also the executive director of the Oregon Cannabis Association, which pushed the new law through the legislative process. “It became clear that unless people could reach outside the state for investment money, we weren’t going to have a very successful market.”
Since March, however, the number of deals that have been struck has been sky-high, with all types of cannabis companies – including retailers and cultivators – raising “hundreds of thousands of dollars” each to grow their companies, Margolis added.
“I think the typical raise is under half a million dollars,” Margolis said.
Sam Chapman, a co-founder of New Economy Consulting, said he’s even seen a few raises between $1 million and $5 million from out-of-state investors.
“Without a doubt, there’s more capital available in Oregon now than prior to the residency requirement being removed. Overall, that’s a positive outcome,” Chapman said.
Sara Batterby, the CEO and president of Hifi Farms, said her company has just completed a $1.375 million seed round with 12 investors thanks to the law change.
Only one of those investors is an Oregon resident. The rest are dispersed throughout the country, including Texas, Georgia, Illinois and Arizona. All threw in cash for controvertible notes that will eventually become equity in Hifi Farms.
Hifi will be using the money to fund an infrastructure expansion on a 50-acre farm in Hillsboro, west of Portland, Batterby said.
“It’s been critical,” Batterby said of the state’s move to nix the residency requirement. “There isn’t the same type of capital that exists in some other cities. It would have been a disaster for the industry if there had been no out-of-state investing.”
Chapman said most of the companies that have raised money in recent months plan to use the money to purchase equipment – such as extraction machines – and fund real estate needs, according to the deals he has examined.
So companies that offer such services to the industry “are going to be in a great spot” as the state starts licensing the first recreational marijuana businesses in the coming months, Chapman said.
There was some concern within the industry that doing away with the residency requirement would lead to outsiders taking over the Oregon cannabis trade.
So far, though, most of the investments involve out-of-state money looking for local partners, as opposed to investors starting up their own companies and trying to muscle out local businesses, Margolis said.
“We have people who are thinking about moving here to open up a cannabis business, and very few of those people are coming here and saying, ‘I’m from Wisconsin, and I’m going to do this all on my own,'” she said. “They’re coming here, and they’re saying, ‘How do I find Oregon partners to invest in?’ And that is almost across the board.”
Chapman said the four states his office gets the most out-of-state investment inquires from are California, Colorado, New York and Florida.
At the same time, Chapman warned that in the long term, the rush of investment could lead to overproduction and an eventual price crash, which has started to materialize in Colorado, arguably because of a supply glut.
“In terms of the land rush that’s coming in for cultivation property right now, I really hope that people are looking at their pro formas and anticipating the eventual drop in price of cannabis, because when you’re going out there to buy that $3 million 100,000-square-foot warehouse, I hope you’re building in the overhead and the eventual drop in price,” Chapman said.
That price drop, he said, is basically guaranteed.
“If it’s $2,000 a pound today, two years from now, it’s probably going to be $1,200, and if you haven’t included that in your pro forma, you’re probably going to be hurting two years from now, and you might be out of business,” Chapman said. “There are a lot of people throwing a lot of money around right now without doing any due diligence, and they’re basically lighting some of that money on fire.”
cannabis investments
By John Schroyer
Out-of-state investors are pumping millions of dollars into Oregon’s marijuana industry now that a restrictive residency requirement has been abolished, giving local cannabis businesses a sorely needed pipeline of money to tap as they grow.
In March, Oregon’s governor signed a law eliminating a rule that required every legal marijuana business to be at least 51% owned by an Oregon resident who lived in the state for at least two years.
As a result, cannabis companies are now free to raise money from out-of-state investors in exchange for equity, making the market much more attractive to deep-pocketed individuals and firms looking to fund marijuana businesses.
“For every five people who came into my office, three or four of them were looking for capital, and they couldn’t find it here in Oregon,” said Portland attorney Amy Margolis, who is also the executive director of the Oregon Cannabis Association, which pushed the new law through the legislative process. “It became clear that unless people could reach outside the state for investment money, we weren’t going to have a very successful market.”
Since March, however, the number of deals that have been struck has been sky-high, with all types of cannabis companies – including retailers and cultivators – raising “hundreds of thousands of dollars” each to grow their companies, Margolis added.
“I think the typical raise is under half a million dollars,” Margolis said.
Sam Chapman, a co-founder of New Economy Consulting, said he’s even seen a few raises between $1 million and $5 million from out-of-state investors.
“Without a doubt, there’s more capital available in Oregon now than prior to the residency requirement being removed. Overall, that’s a positive outcome,” Chapman said.
Sara Batterby, the CEO and president of Hifi Farms, said her company has just completed a $1.375 million seed round with 12 investors thanks to the law change.
Only one of those investors is an Oregon resident. The rest are dispersed throughout the country, including Texas, Georgia, Illinois and Arizona. All threw in cash for controvertible notes that will eventually become equity in Hifi Farms.
Hifi will be using the money to fund an infrastructure expansion on a 50-acre farm in Hillsboro, west of Portland, Batterby said.
“It’s been critical,” Batterby said of the state’s move to nix the residency requirement. “There isn’t the same type of capital that exists in some other cities. It would have been a disaster for the industry if there had been no out-of-state investing.”
Chapman said most of the companies that have raised money in recent months plan to use the money to purchase equipment – such as extraction machines – and fund real estate needs, according to the deals he has examined.
So companies that offer such services to the industry “are going to be in a great spot” as the state starts licensing the first recreational marijuana businesses in the coming months, Chapman said.
There was some concern within the industry that doing away with the residency requirement would lead to outsiders taking over the Oregon cannabis trade.
So far, though, most of the investments involve out-of-state money looking for local partners, as opposed to investors starting up their own companies and trying to muscle out local businesses, Margolis said.
“We have people who are thinking about moving here to open up a cannabis business, and very few of those people are coming here and saying, ‘I’m from Wisconsin, and I’m going to do this all on my own,'” she said. “They’re coming here, and they’re saying, ‘How do I find Oregon partners to invest in?’ And that is almost across the board.”
Chapman said the four states his office gets the most out-of-state investment inquires from are California, Colorado, New York and Florida.
At the same time, Chapman warned that in the long term, the rush of investment could lead to overproduction and an eventual price crash, which has started to materialize in Colorado, arguably because of a supply glut.
“In terms of the land rush that’s coming in for cultivation property right now, I really hope that people are looking at their pro formas and anticipating the eventual drop in price of cannabis, because when you’re going out there to buy that $3 million 100,000-square-foot warehouse, I hope you’re building in the overhead and the eventual drop in price,” Chapman said.
That price drop, he said, is basically guaranteed.
“If it’s $2,000 a pound today, two years from now, it’s probably going to be $1,200, and if you haven’t included that in your pro forma, you’re probably going to be hurting two years from now, and you might be out of business,” Chapman said. “There are a lot of people throwing a lot of money around right now without doing any due diligence, and they’re basically lighting some of that money on fire.”
California Adult Use Measure Receives Key Endorsements
Posted by TWB on July 1, 2016 Ending Marijuana Prohibition, Medical Marijuana Policy.
SACRAMENTO, CA—The campaign in support of the Adult Use of Marijuana Act (AUMA), announced the endorsement of an all-star cast of respected state lawmakers representing communities all across California. Their support follows the announcement by Secretary of State Alex Padilla on Tuesday that the measure has officially qualified for the November 8th General Election ballot in California.
California legislators endorsing the measure – including authors and supporters of the bipartisan Medical Marijuana Regulation and Safety Act (MMRSA) – are:
•Speaker Emeritus Toni G. Atkins (San Diego)
•Assemblyman Rob Bonta (Oakland)
•Assemblyman David Chiu (San Francisco)
•Assemblywoman Susan Talamantes Eggman (Stockton)
•Assemblywoman Cristina Garcia (Bell Gardens)
•Assemblyman Reggie Jones-Sawyer (South Los Angeles)
•Assemblyman Kevin McCarty (Sacramento)
•Assemblyman Bill Quirk (Hayward)
•Senator Mark Leno (San Francisco)
They join a diverse coalition of endorsers in support of AUMA, the largest ever formed in support of marijuana policy reform in our state, including:
•Lieutenant Governor Gavin Newsom
•U.S. Rep. Dana Rohrabacher (R-Huntington Beach)
•U.S. Rep. Ted Lieu (D-Torrance)
•U.S. Rep. Jared Huffman (D-San Rafael)
•California Medical Association
•California Council of Land Trusts
•California Cannabis Industry Association
•California NAACP
•Drug Policy Alliance
•Marijuana Policy Project
•National NORML
•ACLU of California
•California Democratic Party
•California Young Democrats
•Los Angeles County Democratic Party
•San Francisco Democratic Party
•Los Angeles Community Health Project
•Sacramento Black Chamber of Commerce
•Blacks in Law Enforcement of America
•National Latino Officers Association
•William C. Velasquez Institute
The Adult Use of Marijuana Act is a consensus measure based on recognized best practices and recommendations from hundreds of engaged citizens and organizations. It includes strong safeguards for children, workers, local governments and small businesses and strict anti-monopoly provisions and the toughest warning label and marketing-to-kids laws in the nation.
It also closely adheres to the Lieutenant Governor’s Blue Ribbon Commission on Marijuana Policy and the new medical marijuana laws recently passed by a bipartisan majority of the Legislature and signed by Governor Brown (SB 643, AB 266 and AB 243).
Get the full campaign information at: www.letsgetitrightca.org
Special Report: Investing in Marijuana Stocks
Marijuana stocks are gearing up to be huge this year and beyond. Some investors have already banked gains of over 2,000% on some budding marijuana stocks. And as more and more states legalize both medical and recreation weed, those profits are going to keep on growing.
Here's why grass is greener than practically anything else you can invest in right now...
I'm not going to bother with any ethical issues here. Whether you support pot smoking or not, this industry is going to be massive.
For better or worse, marijuana is immensely popular. And its popularity is increasing each and every day...
A recent survey revealed that 7.3% of Americans 12 or older regularly used marijuana in 2012, up from 7% in 2011. That's 7.6 million Americans that light up almost every single day of their lives. Countless millions of others use it occasionally...
And more people use marijuana than are actually estimated (in no small part because people don't like admitting incriminating things about themselves). The real number of smokers has been estimated as high as 50 million.
Most telling is that the new generation of teenagers is smoking more pot than ever. Today's teens are lighting up 80% more than they were in 2008. In fact, more teenagers smoke pot than cigarettes... and you know what a profitable business cigarettes have been — even after they were proven to give you cancer. Marijuana has no proven health effects anywhere near that serious.
It stands to reason that as more and more states open up to legal weed, this new crop of Americans will be buying it up in record numbers.
In fact, the legal marijuana industry in the U.S. already pulled in $5.4 billion last year. That's billion with a 'B'. Just think about that...
Of the 50 states, only four currently have legalized marijuana for recreational purposes and 24 have legalized it for medicinal purposes.
Once the others fall into place, we could be looking at a $200+ billion industry. Whatever your opinions on marijuana may be, there is one thing that cannot be argued: there aren't many chances to get in on the ground floor of an industry that size.
"The demand for marijuana is insatiable," according to Bruce Perlowin, CEO of Hemp Inc. (HEMP). "It's a feeding frenzy for the birth of a new industry."
The trend is clearly growing in favor of marijuana growers and distributors. You can choose to turn up your nose, or you can start cashing in on the feeding frenzy while it's still on the way up. In other words, the time has finally come for marijuana stocks...
After years of wild stock price swings, evolving legislation, and political posturing, the marijuana sector has finally found its first major backer and the big money has already started to stack up behind both recreational and medical marijuana.
PayPal founder and famed venture capitalist Peter Thiel sank $75 million into the space by investing in Privateer Holdings — a Seattle-based company that has large investments in several marijuana-related enterprises.
Thiel’s Founder’s Fund has been in on the ground floor of many other disruptive and wildly profitable sectors like Facebook, Spotify, and Airbnb. It’s safe to say that he knows an emerging industry when he sees it...
And the marijuana industry is going to be massive.
Here’s why the stars are aligning for marijuana right now... and why you should get on board before the next billionaire dumps a ton of money into the sector.
Privateer Holdings currently operates three large companies in the marijuana space.
It operates Canadian medical marijuana producer Tilray, which is a mail-order business for medical marijuana companies in Canada — where medical marijuana regulations are much more relaxed than here in the U.S. Last year alone, it unloaded 35,000 shipments of marijuana.
Privateer also holds Leafly, the world’s largest resource for information about both medical and recreational cannabis. Leafly allows you to explore different cannabis strains for their medical effectiveness, flavors, and overall quality — much like an Angie’s List or Yelp for marijuana.
Leafly is hugely popular in the space: It averages over 4 million monthly visitors to the website. It expects to be profitable by next year.
Now, while both of those companies operate in the medical marijuana space, Privateer is positioning itself for the widespread legalization of recreational use as well.
And right now — especially in the recreational markets — it’s the Wild West out there. If early investors place the right bets, they’ll be rewarded with one of the biggest growth markets in the recent history of investing.
“There are no standards, no leaders, no significant brands — we’re at the point where the industry is being ‘productized,’ where suddenly someone buying cannabis might begin seeing it packaged nicely, in a way that implies safety, consistency and quality. That’s a big leap from buying something in a Ziploc bag,” noted co-founder and CEO of Privateer Brendan Kennedy.
I’ll say...
Here's how Privateer Holdings co-founder and Chief Financial Officer Michael Blue explains the industry growth:
Since we announced that Founders Fund made the first institutional investment in the cannabis industry in January, we’ve seen the profile of our investor base change in ways that would have been unthinkable five years ago when we set out to transform this industry
We closed the Series B round with a group of sophisticated family offices and institutional investors who made seven- and eight-figure investments. That’s a vote of confidence for the entire industry and an important step forward in finally ending cannabis prohibition.
That round of financing has closed now, after raising $75 million in series B funding — the largest private capital fund raising the industry has ever seen. All told, the start-up has raised over $82 million and doesn't look to be slowing down anytime soon.
"This is the fastest-growing industry in America,'' according to Troy Dayton, CEO of ArcView Group. "Despite all the stigma, people are recognizing this could be the next great American industry.''
ArcView is a research and investment firm focused on "canna-business."
It just released a market study that found a 74% increase in marijuana sales in the U.S. from 2013 to 2014. That massive jump is due primarily to legalization in Colorado and Washington. This will continue. In fact, next year Oregon and Alaska will start selling legal pot — and many more will follow.
Another factor is more relaxed regulations regarding medical marijuana. While only a couple states have outright legalized it, 23 states have already approved medical marijuana. Medicinal marijuana sales in California alone could account for nearly half of a $2.7 billion market.
ArcView is predicting that market will swell to $10 billion in five years' time...
Now, that is an impressive number, but when marijuana is totally legalized and destigmatized, ArcView expects it to become a $100 billion to $200 billion-a-year business.
Special Report: Investing in Marijuana Stocks
Marijuana stocks are gearing up to be huge this year and beyond. Some investors have already banked gains of over 2,000% on some budding marijuana stocks. And as more and more states legalize both medical and recreation weed, those profits are going to keep on growing.
Here's why grass is greener than practically anything else you can invest in right now...
I'm not going to bother with any ethical issues here. Whether you support pot smoking or not, this industry is going to be massive.
For better or worse, marijuana is immensely popular. And its popularity is increasing each and every day...
A recent survey revealed that 7.3% of Americans 12 or older regularly used marijuana in 2012, up from 7% in 2011. That's 7.6 million Americans that light up almost every single day of their lives. Countless millions of others use it occasionally...
And more people use marijuana than are actually estimated (in no small part because people don't like admitting incriminating things about themselves). The real number of smokers has been estimated as high as 50 million.
Most telling is that the new generation of teenagers is smoking more pot than ever. Today's teens are lighting up 80% more than they were in 2008. In fact, more teenagers smoke pot than cigarettes... and you know what a profitable business cigarettes have been — even after they were proven to give you cancer. Marijuana has no proven health effects anywhere near that serious.
It stands to reason that as more and more states open up to legal weed, this new crop of Americans will be buying it up in record numbers.
In fact, the legal marijuana industry in the U.S. already pulled in $5.4 billion last year. That's billion with a 'B'. Just think about that...
Of the 50 states, only four currently have legalized marijuana for recreational purposes and 24 have legalized it for medicinal purposes.
Once the others fall into place, we could be looking at a $200+ billion industry. Whatever your opinions on marijuana may be, there is one thing that cannot be argued: there aren't many chances to get in on the ground floor of an industry that size.
"The demand for marijuana is insatiable," according to Bruce Perlowin, CEO of Hemp Inc. (HEMP). "It's a feeding frenzy for the birth of a new industry."
The trend is clearly growing in favor of marijuana growers and distributors. You can choose to turn up your nose, or you can start cashing in on the feeding frenzy while it's still on the way up. In other words, the time has finally come for marijuana stocks...
After years of wild stock price swings, evolving legislation, and political posturing, the marijuana sector has finally found its first major backer and the big money has already started to stack up behind both recreational and medical marijuana.
PayPal founder and famed venture capitalist Peter Thiel sank $75 million into the space by investing in Privateer Holdings — a Seattle-based company that has large investments in several marijuana-related enterprises.
Thiel’s Founder’s Fund has been in on the ground floor of many other disruptive and wildly profitable sectors like Facebook, Spotify, and Airbnb. It’s safe to say that he knows an emerging industry when he sees it...
And the marijuana industry is going to be massive.
Here’s why the stars are aligning for marijuana right now... and why you should get on board before the next billionaire dumps a ton of money into the sector.
Privateer Holdings currently operates three large companies in the marijuana space.
It operates Canadian medical marijuana producer Tilray, which is a mail-order business for medical marijuana companies in Canada — where medical marijuana regulations are much more relaxed than here in the U.S. Last year alone, it unloaded 35,000 shipments of marijuana.
Privateer also holds Leafly, the world’s largest resource for information about both medical and recreational cannabis. Leafly allows you to explore different cannabis strains for their medical effectiveness, flavors, and overall quality — much like an Angie’s List or Yelp for marijuana.
Leafly is hugely popular in the space: It averages over 4 million monthly visitors to the website. It expects to be profitable by next year.
Now, while both of those companies operate in the medical marijuana space, Privateer is positioning itself for the widespread legalization of recreational use as well.
And right now — especially in the recreational markets — it’s the Wild West out there. If early investors place the right bets, they’ll be rewarded with one of the biggest growth markets in the recent history of investing.
“There are no standards, no leaders, no significant brands — we’re at the point where the industry is being ‘productized,’ where suddenly someone buying cannabis might begin seeing it packaged nicely, in a way that implies safety, consistency and quality. That’s a big leap from buying something in a Ziploc bag,” noted co-founder and CEO of Privateer Brendan Kennedy.
I’ll say...
Here's how Privateer Holdings co-founder and Chief Financial Officer Michael Blue explains the industry growth:
Since we announced that Founders Fund made the first institutional investment in the cannabis industry in January, we’ve seen the profile of our investor base change in ways that would have been unthinkable five years ago when we set out to transform this industry
We closed the Series B round with a group of sophisticated family offices and institutional investors who made seven- and eight-figure investments. That’s a vote of confidence for the entire industry and an important step forward in finally ending cannabis prohibition.
That round of financing has closed now, after raising $75 million in series B funding — the largest private capital fund raising the industry has ever seen. All told, the start-up has raised over $82 million and doesn't look to be slowing down anytime soon.
"This is the fastest-growing industry in America,'' according to Troy Dayton, CEO of ArcView Group. "Despite all the stigma, people are recognizing this could be the next great American industry.''
ArcView is a research and investment firm focused on "canna-business."
It just released a market study that found a 74% increase in marijuana sales in the U.S. from 2013 to 2014. That massive jump is due primarily to legalization in Colorado and Washington. This will continue. In fact, next year Oregon and Alaska will start selling legal pot — and many more will follow.
Another factor is more relaxed regulations regarding medical marijuana. While only a couple states have outright legalized it, 23 states have already approved medical marijuana. Medicinal marijuana sales in California alone could account for nearly half of a $2.7 billion market.
ArcView is predicting that market will swell to $10 billion in five years' time...
Now, that is an impressive number, but when marijuana is totally legalized and destigmatized, ArcView expects it to become a $100 billion to $200 billion-a-year business.
Holding and waiting for news
Thanks Doris but there are lots of people who post informative information on this board. This company went to $1.20 PPS back in 2014 and it's poised to do it again. Buy November we will see phenomenal numbers here, possibly passing 2014 highs. I have 3/4 million shares and I'm buying more on Monday. This industry is going to be incredibly huge. The smart money is loading at these very low PPS. I hope you buy as much as you can afford, you will be very well rewarded. Good luck to you and the rest of my peeps on this board. CIAO (Italian for, good by for now)
I think everyone believes California is the big bang we are all waiting for, plus November elections
Things are getting hotter and I don't mean the temperature LOL
Assessing the Marijuana Investment Climate: Q&A With First Capital Venture’s Erin Turoff
By John Schroyer
Erin Turoff packed her belongings and moved to Denver from New York City earlier this year for one reason: to get into marijuana investing.
The seasoned asset management professional – who previously rubbed elbows with institutional investors and hedge fund managers – is convinced cannabis is the investment world’s next big thing.
And she’s not going to miss the boat.
After moving to Colorado, Turoff landed a position as the chief operating officer and managing director of First Capital Ventures, a Denver-based investment fund that aims to pump tens of millions into the legal marijuana industry.
Marijuana Business Daily caught up with her recently to get her thoughts on the industry and where she sees the best investment opportunities.
Why did you decide to move to Colorado to enter cannabis investing instead of Nevada, California or another state?
Colorado is at the forefront of the industry. They’re the leader in setting the pace for other states, and I wanted to get in on the ground floor as early as possible. That’s where you make the most return on your investment.
I think a year from now it’s going to be late for a lot of investors to get into this space. And I think right now is when you want to put your money into cannabis, just given how the laws are changing and how everything is rolling out across the nation.
Do you have any big picture goals with First Capital that you can share?
Our goal is (to raise) $50 million. And for a first-time fund I think that’s a healthy number. We’re looking to get that completed by the end of the year.
We signed our first term sheet in April with an edibles and chocolate company called Coda Signature, which is based in Trinidad, Colorado. We’re trying to help them get off the ground and get into as many dispensaries as possible – do a national rollout and kind of put together a strategic plan for getting into other states eventually.
Is First Capital going to be investing in other plant-touching companies?
We’re primarily investing in non-plant-touching companies, but definitely ancillary products as well. We are doing a lot of stuff right now with real estate, and then you’ve got industrial hemp to round it out.
We will definitely go international. But right now we’re focused on anything in the U.S., with a focus on states where it’s already been legalized. Israel is doing a lot of cool stuff with cannabis, so we’d love to get into that market at some point. We have a heavy focus on California, Colorado, New Mexico. We’re a lot more comfortable with the western region, but we’re definitely going all over the place.
Do you expect more institutional investors to warm to the cannabis industry in coming years?
Absolutely. I think the institutional investors will be a little bit slower to move, which is always the case with any type of investment product, especially the new ones. I would say the ones I’d consider the thought leaders in the industry are getting in now. I think with the institutional investors you really need a conversation one-on-one, maybe a phone call, just to ask the question if they’re open to cannabis.
Will there be more capital available for growth and startups in the future?
I think there will be a lot more capital available as time goes on. I think it’s probably difficult to find the funds that are investing in these types of businesses right now. But my hope is that more cannabis-only funds start popping up as people get more comfortable with the idea of it. I think you’ll start to see a ton of portfolio companies hit the market in all different states all over the country.
So I think that’s just ramping up. It’s probably less than 5% mature right now. It’s got a really long way to go.
What have you learned in just the past few weeks since you started? What did you mean by there being more interest than you expected?
Given my background, I haven’t had any discussions with investors about cannabis up until this point.
But over the last few weeks, just talking to investors and my personal network, I’m shocked at how positive the reception has been and how interesting cannabis is to investors and people in general right now.
This is an interesting area of private equity and venture capital at the moment, and there’s a learning curve, unfortunately. So part of our challenge is educating people about the industry itself, giving predictions that are thoughtful about how the states are going to roll out and how the industry is going to shape out over time.
Are there any particular niches in the industry that you see as particularly good or bad investments?
I’d say we’re definitely technology-oriented, so we definitely have a preference and look for companies that have some sort of angle of technology within cannabis.
It's not just the temperature that's getting hot:
Assessing the Marijuana Investment Climate: Q&A With First Capital Venture’s Erin Turoff
By John Schroyer
Erin Turoff packed her belongings and moved to Denver from New York City earlier this year for one reason: to get into marijuana investing.
The seasoned asset management professional – who previously rubbed elbows with institutional investors and hedge fund managers – is convinced cannabis is the investment world’s next big thing.
And she’s not going to miss the boat.
After moving to Colorado, Turoff landed a position as the chief operating officer and managing director of First Capital Ventures, a Denver-based investment fund that aims to pump tens of millions into the legal marijuana industry.
Marijuana Business Daily caught up with her recently to get her thoughts on the industry and where she sees the best investment opportunities.
Why did you decide to move to Colorado to enter cannabis investing instead of Nevada, California or another state?
Colorado is at the forefront of the industry. They’re the leader in setting the pace for other states, and I wanted to get in on the ground floor as early as possible. That’s where you make the most return on your investment.
I think a year from now it’s going to be late for a lot of investors to get into this space. And I think right now is when you want to put your money into cannabis, just given how the laws are changing and how everything is rolling out across the nation.
Do you have any big picture goals with First Capital that you can share?
Our goal is (to raise) $50 million. And for a first-time fund I think that’s a healthy number. We’re looking to get that completed by the end of the year.
We signed our first term sheet in April with an edibles and chocolate company called Coda Signature, which is based in Trinidad, Colorado. We’re trying to help them get off the ground and get into as many dispensaries as possible – do a national rollout and kind of put together a strategic plan for getting into other states eventually.
Is First Capital going to be investing in other plant-touching companies?
We’re primarily investing in non-plant-touching companies, but definitely ancillary products as well. We are doing a lot of stuff right now with real estate, and then you’ve got industrial hemp to round it out.
We will definitely go international. But right now we’re focused on anything in the U.S., with a focus on states where it’s already been legalized. Israel is doing a lot of cool stuff with cannabis, so we’d love to get into that market at some point. We have a heavy focus on California, Colorado, New Mexico. We’re a lot more comfortable with the western region, but we’re definitely going all over the place.
Do you expect more institutional investors to warm to the cannabis industry in coming years?
Absolutely. I think the institutional investors will be a little bit slower to move, which is always the case with any type of investment product, especially the new ones. I would say the ones I’d consider the thought leaders in the industry are getting in now. I think with the institutional investors you really need a conversation one-on-one, maybe a phone call, just to ask the question if they’re open to cannabis.
Will there be more capital available for growth and startups in the future?
I think there will be a lot more capital available as time goes on. I think it’s probably difficult to find the funds that are investing in these types of businesses right now. But my hope is that more cannabis-only funds start popping up as people get more comfortable with the idea of it. I think you’ll start to see a ton of portfolio companies hit the market in all different states all over the country.
So I think that’s just ramping up. It’s probably less than 5% mature right now. It’s got a really long way to go.
What have you learned in just the past few weeks since you started? What did you mean by there being more interest than you expected?
Given my background, I haven’t had any discussions with investors about cannabis up until this point.
But over the last few weeks, just talking to investors and my personal network, I’m shocked at how positive the reception has been and how interesting cannabis is to investors and people in general right now.
This is an interesting area of private equity and venture capital at the moment, and there’s a learning curve, unfortunately. So part of our challenge is educating people about the industry itself, giving predictions that are thoughtful about how the states are going to roll out and how the industry is going to shape out over time.
Are there any particular niches in the industry that you see as particularly good or bad investments?
I’d say we’re definitely technology-oriented, so we definitely have a preference and look for companies that have some sort of angle of technology within cannabis.